• Health
  • By Laura Sinpetru
  • January 8th, 2013
New Lilly, Boehringer Diabetes Drug Performs Well in Trial

New Lilly, Boehringer Diabetes Drug Performs Well in Trial

Empagliflozin, a treatment for type 2 diabetes, managed to lower blood sugar levels